
Our Mission: To better understand the biomechanics of the skeleton in health and disease.


New treatments under development will make the skeleton stronger by stimulating
new bone formation to augment weakened structures within bones. We
investigated a new drug called PTH(1-34) or teriparatide. This drug
substantially improved bone structure after several months of treatment.
For more information, click here.

Sex hormones affect the way the skeleton develops and also play important roles
in the development of osteoporosis. For instance, estrogen
suppresses bone growth but then preserves bone structure throughout adulthood.
At the menopause, estrogen levels drop and the skeleton rapidly loses bone mass.
On the other hand estrogen loss allows the periosteal (outside) diameter of
bones to grow. For more about this, click here.

Osteoporosis is a multifaceted disease. Bone becomes
porous - hence the name of the disease - but in addition there are many changes
to bone tissue that alter bone strength. Changes occur in the dimensions
of the mineral crystals, in the rigidity of the collagen matrix, in the
microarchitecture of trabecular struts, and in the size and shape of the bones.
All of these factors contribute to bone fragility and fracture risk.
Drug treatments for osteoporosis do not only affect bone porosity but also
affect bone size, architecture and mineral. The effects of several
osteoporosis drugs are discussed here.

The exponential rise in hip-fracture risk with aging is not fully explained by the corresponding fall in bone mineral density of the proximal femur. Instead, aging affects hip-fracture risk independently of bone mineral density, suggesting that there are other important age-related changes that must be considered. Of course, falls are important. Elderly people are more likely to fall down; therefore their risk of hip fracture should increase. In addition, ageing causes structural changes in the proximal femur that might increase the risk of fracture should someone fall on their side. Over a decade ago, Yoshikawa et al showed that bone loss occurs preferentially on the superior aspect of the femoral neck. This region of the femoral neck is under minimum mechanical stress during walking, whereas a fall on the hip reverses the stress pattern causing high compressive stresses at the superior neck...more
Back to Home Page
Copyright © 2005-2008 Charles H. Turner. All
rights reserved.